About Genuity Science
Genuity Science is a company based in Boston (United States) founded in 2013 by Jeff Gulcher was acquired by Hibercell in August 2021.. Genuity Science has raised $515 million across 3 funding rounds from investors including Temasek, HiberCell and Ireland Strategic Investment Fund. Genuity Science has completed 1 acquisition, including Genomics Medicine Ireland. Genuity Science offers products and services including Target Discovery, Portfolio Optimization, Clinical Trials, and Biomarker Discovery. Genuity Science operates in a competitive market with competitors including Helix, Benchling, BioAge Labs, Ingenuity Systems and Cellworks, among others.
- Headquarter Boston, United States
- Founders Jeff Gulcher
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Genuity Science
Genuity Science offers a comprehensive portfolio of products and services, including Target Discovery, Portfolio Optimization, Clinical Trials, and Biomarker Discovery. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Identifies novel targets using genetic evidence for drug development research.
Validates targets and biomarkers to optimize research investments effectively.
Designs studies by identifying sub-populations for better trial outcomes.
Discovers biomarkers for disease stratification and targeted therapies.
Unlock access to complete
Unlock access to complete
Funding Insights of Genuity Science
Genuity Science has successfully raised a total of $515M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $200 million completed in November 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series C — $200.0M
-
First Round
First Round
(01 May 2017)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2018 | Amount | Series C - Genuity Science | Valuation | Ireland Strategic Investment Fund | |
| Sep, 2017 | Amount | Series B - Genuity Science | Valuation | Sequoia Capital | |
| May, 2017 | Amount | Series B - Genuity Science | Valuation | Temasek , Yunfeng Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Genuity Science
Genuity Science has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Temasek, HiberCell and Ireland Strategic Investment Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
An investment platform is provided for diverse sectors and geographies.
|
Founded Year | Domain | Location | |
|
Private equity investments are managed by Yunfeng Capital in China.
|
Founded Year | Domain | Location | |
|
Sequoia Capital is engaged in venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Genuity Science
Genuity Science has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Genomics Medicine Ireland. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Population genomics database for disease risk analysis is developed.
|
2015 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Genuity Science
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Genuity Science Comparisons
Competitors of Genuity Science
Genuity Science operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Benchling, BioAge Labs, Ingenuity Systems and Cellworks, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genomic database for clinical research is provided.
|
|
| domain | founded_year | HQ Location |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| domain | founded_year | HQ Location |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| domain | founded_year | HQ Location |
Genomic data is analyzed and interpreted via web-based applications.
|
|
| domain | founded_year | HQ Location |
Biosimulation platform developed for therapeutic design in life sciences.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Genuity Science
Frequently Asked Questions about Genuity Science
When was Genuity Science founded?
Genuity Science was founded in 2013 and raised its 1st funding round 4 years after it was founded.
Where is Genuity Science located?
Genuity Science is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Who is the current CEO of Genuity Science?
Rob Brainin is the current CEO of Genuity Science.
Is Genuity Science a funded company?
Genuity Science is a funded company, having raised a total of $515M across 3 funding rounds to date. The company's 1st funding round was a Series B of $75M, raised on May 01, 2017.
What does Genuity Science do?
Founded in 2013 and based in Boston, United States, Genuity Science operates in the biotechnology sector. Omics data, including genomic and phenotypic information, is analyzed through AI-driven tools. These solutions support drug discovery, design, and development, as well as clinical trial studies and broader genomic research. Services are tailored for researchers seeking efficient data interpretation in scientific applications.
Who are the top competitors of Genuity Science?
Genuity Science's top competitors include Helix, Benchling and BioAge Labs.
What products or services does Genuity Science offer?
Genuity Science offers Target Discovery, Portfolio Optimization, Clinical Trials, and Biomarker Discovery.
How many acquisitions has Genuity Science made?
Genuity Science has made 1 acquisition, including Genomics Medicine Ireland.
Who are Genuity Science's investors?
Genuity Science has 7 investors. Key investors include Temasek, HiberCell, Ireland Strategic Investment Fund, Yunfeng Capital, and Sequoia Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.